{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:37:19Z","timestamp":1792787839796,"version":"4.5.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T00:00:00Z","timestamp":1789862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:00:00Z","timestamp":1790380800000},"content-version":"vor","delay-in-days":6,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Max Planck Institute of Biochemistry","id":[{"id":"https:\/\/ror.org\/04py35477","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Proteom"],"published-print":{"date-parts":[[2026,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Precision oncology has largely relied on genomic and transcriptomic sequencing to guide therapy selection in patients with advanced cancer. However, these molecular layers do not fully capture the functional state of tumors, as proteins largely represent the active effectors of cellular processes and signaling pathways. Integrating proteomic and phosphoproteomic measurements with genomic data has therefore emerged as an important objective in translational oncology. In routine clinical workflows, tumor biopsies are frequently processed using DNA\/RNA extraction kits such as the Qiagen AllPrep system, which generates a protein-rich flowthrough that is typically discarded.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Here we systematically evaluated whether the residual protein fraction generated during Qiagen AllPrep DNA\/RNA extraction can serve as a reliable source for mass spectrometry\u2013based proteomics in clinical tumor biopsies. Within the Copenhagen Prospective Personalized Oncology (CoPPO) precision oncology trial, residual protein fractions from metastatic cancer biopsies were recovered, precipitated, and processed using optimized workflows for liquid chromatography\u2013mass spectrometry. We established procedures for protein recovery, digestion, and peptide cleanup, and evaluated multiple acquisition strategies including data-dependent acquisition (DDA) and data-independent acquisition (DIA). We further assessed sample stability during long-term storage, analytical reproducibility, scalability, and compatibility with phosphoproteomics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Optimized single-shot workflows consistently generated deep proteomes from AllPrep-derived biopsy material, quantifying more than 10,000 protein groups in DIA analyses. Protein integrity was preserved in samples stored at \u2212\u200980\u00a0\u00b0C for up to five years. The resulting proteomes retained tissue-associated biological signatures and quantified protein products corresponding to approximately 71% of genes represented on the FoundationOne\n                      <jats:sup>\u00ae<\/jats:sup>\n                      CDx panel. Phosphoproteomic analyses identified more than 10,000 phosphorylation sites associated with key oncogenic signaling pathways including AKT1, BRAF, and EGFR. Implementation of short liquid chromatography gradients enabled high-throughput analysis of up to 60 proteomes per day without compromising data quality.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Residual protein fractions from Qiagen AllPrep DNA\/RNA extraction provide a scalable resource for deep proteomic and phosphoproteomic profiling from the same biopsy used for genomic and transcriptomic analyses. This workflow enables integrated proteogenomic characterization from a single clinical sample and provides a framework for integrated proteogenomic studies in precision oncology.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12014-026-09632-1","type":"journal-article","created":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T08:45:02Z","timestamp":1789893902000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Scalable clinical proteomics from DNA\/RNA extraction flowthroughs enables integrated proteogenomic profiling from a single cancer biopsy"],"prefix":"10.1186","volume":"23","author":[{"given":"Filip","family":"Mundt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annelaura","family":"Bach Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juanjuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josephine","family":"Kerzel Duel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Westmose Yde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Amnitzb\u00f8ll Eriksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrik","family":"Lassen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Finn","family":"Cilius Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristoffer","family":"Rohrberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,20]]},"reference":[{"issue":"1","key":"9632_CR1","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13073-019-0703-1","volume":"12","author":"ER Malone","year":"2020","unstructured":"Malone ER, et al. Molecular profiling for precision cancer therapies. Genome Med. 2020;12(1):8.","journal-title":"Genome Med"},{"issue":"4","key":"9632_CR2","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1158\/1078-0432.CCR-18-1780","volume":"25","author":"IV Tuxen","year":"2019","unstructured":"Tuxen IV, et al. Copenhagen Prospective Personalized Oncology (CoPPO)-Clinical Utility of Using Molecular Profiling to Select Patients to Phase I Trials. Clin Cancer Res. 2019;25(4):1239\u201347.","journal-title":"Clin Cancer Res"},{"key":"9632_CR3","doi-asserted-by":"publisher","unstructured":"Yaffe MB. Why geneticists stole cancer research even though cancer is primarily a signaling disease. Sci Signal. 2019 Jan 22;12(565):eaaw3483. https:\/\/doi.org\/10.1126\/scisignal.aaw3483","DOI":"10.1126\/scisignal.aaw3483"},{"issue":"7605","key":"9632_CR4","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nature18003","volume":"534","author":"P Mertins","year":"2016","unstructured":"Mertins P, et al. Proteogenomics connects somatic mutations to signalling in breast cancer. Nature. 2016;534(7605):55\u201362.","journal-title":"Nature"},{"issue":"10","key":"9632_CR5","doi-asserted-by":"publisher","first-page":"2732","DOI":"10.1158\/0008-5472.CAN-17-1990","volume":"78","author":"F Mundt","year":"2018","unstructured":"Mundt F, et al. Mass Spectrometry-Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast Cancers. Cancer Res. 2018;78(10):2732\u201346.","journal-title":"Cancer Res"},{"issue":"1","key":"9632_CR6","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1074\/mcp.M116.060301","volume":"16","author":"J Wang","year":"2017","unstructured":"Wang J, et al. Proteome Profiling Outperforms Transcriptome Profiling for Coexpression Based Gene Function Prediction. Mol Cell Proteom. 2017;16(1):121\u201334.","journal-title":"Mol Cell Proteom"},{"issue":"3","key":"9632_CR7","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.ccell.2018.08.004","volume":"34","author":"TC Archer","year":"2018","unstructured":"Archer TC, et al. Proteomics, Post-translational Modifications, and Integrative Analyses Reveal Molecular Heterogeneity within Medulloblastoma Subgroups. Cancer Cell. 2018;34(3):396\u2013e4108.","journal-title":"Cancer Cell"},{"issue":"1","key":"9632_CR8","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.cell.2018.08.065","volume":"175","author":"F Coscia","year":"2018","unstructured":"Coscia F, et al. Multi-level Proteomics Identifies CT45 as a Chemosensitivity Mediator and Immunotherapy Target in Ovarian Cancer. Cell. 2018;175(1):159\u2013e17016.","journal-title":"Cell"},{"issue":"7758","key":"9632_CR9","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/s41586-019-1173-8","volume":"569","author":"MA Eckert","year":"2019","unstructured":"Eckert MA, et al. Proteomics reveals NNMT as a master metabolic regulator of cancer-associated fibroblasts. Nature. 2019;569(7758):723\u20138.","journal-title":"Nature"},{"issue":"1","key":"9632_CR10","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1038\/s41467-019-09018-y","volume":"10","author":"HJ Johansson","year":"2019","unstructured":"Johansson HJ, et al. Breast cancer quantitative proteome and proteogenomic landscape. Nat Commun. 2019;10(1):1600.","journal-title":"Nat Commun"},{"issue":"8","key":"9632_CR11","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1002\/1878-0261.12326","volume":"12","author":"S Doll","year":"2018","unstructured":"Doll S, et al. Rapid proteomic analysis for solid tumors reveals LSD1 as a drug target in an end-stage cancer patient. Mol Oncol. 2018;12(8):1296\u2013307.","journal-title":"Mol Oncol"},{"issue":"1","key":"9632_CR12","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1002\/path.5420","volume":"251","author":"F Coscia","year":"2020","unstructured":"Coscia F, et al. A streamlined mass spectrometry-based proteomics workflow for large-scale FFPE tissue analysis. J Pathol. 2020;251(1):100\u201312.","journal-title":"J Pathol"},{"issue":"1","key":"9632_CR13","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/s44318-024-00289-w","volume":"44","author":"J Tushaus","year":"2025","unstructured":"Tushaus J, et al. Towards routine proteome profiling of FFPE tissue: insights from a 1,220-case pan-cancer study. EMBO J. 2025;44(1):304\u201329.","journal-title":"EMBO J"},{"issue":"4771","key":"9632_CR14","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1126\/science.233.4771.1367.f","volume":"233","author":"JG Gall","year":"1986","unstructured":"Gall JG. Human genome sequence. Science. 1986;233(4771):1367\u20138.","journal-title":"Science"},{"issue":"1","key":"9632_CR15","first-page":"105","volume":"1805","author":"A Marusyk","year":"2010","unstructured":"Marusyk A, Polyak K. Tumor heterogeneity: causes and consequences. Biochim Biophys Acta. 2010;1805(1):105\u201317.","journal-title":"Biochim Biophys Acta"},{"issue":"8","key":"9632_CR16","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1038\/nprot.2007.261","volume":"2","author":"J Rappsilber","year":"2007","unstructured":"Rappsilber J, Mann M, Ishihama Y. Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips. Nat Protoc. 2007;2(8):1896\u2013906.","journal-title":"Nat Protoc"},{"issue":"1","key":"9632_CR17","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1146\/annurev-anchem-071015-041535","volume":"9","author":"LC Gillet","year":"2016","unstructured":"Gillet LC, Leitner A, Aebersold R. Mass Spectrometry Applied to Bottom-Up Proteomics: Entering the High-Throughput Era for Hypothesis Testing. Annu Rev Anal Chem (Palo Alto Calif). 2016;9(1):449\u201372.","journal-title":"Annu Rev Anal Chem (Palo Alto Calif)"},{"issue":"8","key":"9632_CR18","doi-asserted-by":"publisher","first-page":"e8126","DOI":"10.15252\/msb.20178126","volume":"14","author":"C Ludwig","year":"2018","unstructured":"Ludwig C, et al. Data-independent acquisition-based SWATH-MS for quantitative proteomics: a tutorial. Mol Syst Biol. 2018;14(8):e8126.","journal-title":"Mol Syst Biol"},{"issue":"12","key":"9632_CR19","doi-asserted-by":"publisher","first-page":"5378","DOI":"10.1021\/acs.jproteome.5b00932","volume":"14","author":"F Meier","year":"2015","unstructured":"Meier F, et al. Parallel Accumulation-Serial Fragmentation (PASEF): Multiplying Sequencing Speed and Sensitivity by Synchronized Scans in a Trapped Ion Mobility Device. J Proteome Res. 2015;14(12):5378\u201387.","journal-title":"J Proteome Res"},{"issue":"12","key":"9632_CR20","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1038\/s41592-020-00998-0","volume":"17","author":"F Meier","year":"2020","unstructured":"Meier F, et al. diaPASEF: parallel accumulation-serial fragmentation combined with data-independent acquisition. Nat Methods. 2020;17(12):1229\u201336.","journal-title":"Nat Methods"},{"issue":"9","key":"9632_CR21","doi-asserted-by":"publisher","first-page":"100279","DOI":"10.1016\/j.mcpro.2022.100279","volume":"21","author":"P Skowronek","year":"2022","unstructured":"Skowronek P, et al. Rapid and In-Depth Coverage of the (Phospho-)Proteome With Deep Libraries and Optimal Window Design for dia-PASEF. Mol Cell Proteom. 2022;21(9):100279.","journal-title":"Mol Cell Proteom"},{"issue":"12","key":"9632_CR22","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1038\/nprot.2016.136","volume":"11","author":"S Tyanova","year":"2016","unstructured":"Tyanova S, Temu T, Cox J. The MaxQuant computational platform for mass spectrometry-based shotgun proteomics. Nat Protoc. 2016;11(12):2301\u201319.","journal-title":"Nat Protoc"},{"issue":"1","key":"9632_CR23","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41592-019-0638-x","volume":"17","author":"V Demichev","year":"2020","unstructured":"Demichev V, et al. DIA-NN: neural networks and interference correction enable deep proteome coverage in high throughput. Nat Methods. 2020;17(1):41\u20134.","journal-title":"Nat Methods"},{"issue":"11","key":"9632_CR24","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1074\/mcp.TIR118.000853","volume":"17","author":"N Bache","year":"2018","unstructured":"Bache N, et al. A Novel LC System Embeds Analytes in Pre-formed Gradients for Rapid, Ultra-robust Proteomics. Mol Cell Proteom. 2018;17(11):2284\u201396.","journal-title":"Mol Cell Proteom"},{"issue":"3","key":"9632_CR25","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/sj.onc.1201947","volume":"17","author":"A Bellacosa","year":"1998","unstructured":"Bellacosa A, et al. Akt activation by growth factors is a multiple-step process: the role of the PH domain. Oncogene. 1998;17(3):313\u201325.","journal-title":"Oncogene"},{"issue":"3","key":"9632_CR26","doi-asserted-by":"publisher","first-page":"e0152280","DOI":"10.1371\/journal.pone.0152280","volume":"11","author":"X Tan","year":"2016","unstructured":"Tan X, et al. Phosphoproteome Analysis of Invasion and Metastasis-Related Factors in Pancreatic Cancer Cells. PLoS ONE. 2016;11(3):e0152280.","journal-title":"PLoS ONE"},{"issue":"7","key":"9632_CR27","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1074\/mcp.M113.036392","volume":"13","author":"P Mertins","year":"2014","unstructured":"Mertins P, et al. Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteom. 2014;13(7):1690\u2013704.","journal-title":"Mol Cell Proteom"},{"issue":"5","key":"9632_CR28","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/nsmb.2022","volume":"18","author":"A Marquette","year":"2011","unstructured":"Marquette A, et al. PDE4 cooperate to induce RAF isoform switching in melanoma. Nat Struct Mol Biol. 2011;18(5):584\u201391.","journal-title":"Nat Struct Mol Biol"},{"issue":"3","key":"9632_CR29","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1128\/MCB.00569-09","volume":"30","author":"DA Ritt","year":"2010","unstructured":"Ritt DA, et al. Impact of feedback phosphorylation and Raf heterodimerization on normal and mutant B-Raf signaling. Mol Cell Biol. 2010;30(3):806\u201319.","journal-title":"Mol Cell Biol"},{"issue":"35","key":"9632_CR30","doi-asserted-by":"publisher","first-page":"27354","DOI":"10.1016\/S0021-9258(19)61518-8","volume":"275","author":"KL Guan","year":"2000","unstructured":"Guan KL, et al. Negative regulation of the serine\/threonine kinase B-Raf by Akt. J Biol Chem. 2000;275(35):27354\u20139.","journal-title":"J Biol Chem"},{"issue":"9","key":"9632_CR31","doi-asserted-by":"publisher","first-page":"3429","DOI":"10.1158\/0008-5472.CAN-07-5867","volume":"68","author":"M Cheung","year":"2008","unstructured":"Cheung M, et al. Akt3 and mutant V600E B-Raf cooperate to promote early melanoma development. Cancer Res. 2008;68(9):3429\u201339.","journal-title":"Cancer Res"},{"issue":"6","key":"9632_CR32","doi-asserted-by":"publisher","first-page":"3803","DOI":"10.1074\/jbc.275.6.3803","volume":"275","author":"MC MacNicol","year":"2000","unstructured":"MacNicol MC, Muslin AJ, MacNicol AM. Disruption of the 14-3-3 binding site within the B-Raf kinase domain uncouples catalytic activity from PC12 cell differentiation. J Biol Chem. 2000;275(6):3803\u20139.","journal-title":"J Biol Chem"},{"issue":"33","key":"9632_CR33","doi-asserted-by":"publisher","first-page":"22159","DOI":"10.1016\/S0021-9258(18)54548-8","volume":"266","author":"FA Gonzalez","year":"1991","unstructured":"Gonzalez FA, Raden DL, Davis RJ. Identification of substrate recognition determinants for human ERK1 and ERK2 protein kinases. J Biol Chem. 1991;266(33):22159\u201363.","journal-title":"J Biol Chem"},{"issue":"1","key":"9632_CR34","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.bbrc.2019.07.126","volume":"518","author":"T Lan","year":"2019","unstructured":"Lan T, et al. Type II cGMP-dependent protein kinase phosphorylates EGFR at threonine 669 and thereby inhibits its activation. Biochem Biophys Res Commun. 2019;518(1):14\u20138.","journal-title":"Biochem Biophys Res Commun"},{"issue":"14","key":"9632_CR35","doi-asserted-by":"publisher","first-page":"e107182","DOI":"10.15252\/embj.2020107182","volume":"40","author":"MP Smith","year":"2021","unstructured":"Smith MP, et al. Reciprocal priming between receptor tyrosine kinases at recycling endosomes orchestrates cellular signalling outputs. EMBO J. 2021;40(14):e107182.","journal-title":"EMBO J"},{"issue":"3","key":"9632_CR36","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1021\/pr101075e","volume":"10","author":"V Chumbalkar","year":"2011","unstructured":"Chumbalkar V, et al. Analysis of phosphotyrosine signaling in glioblastoma identifies STAT5 as a novel downstream target of DeltaEGFR. J Proteome Res. 2011;10(3):1343\u201352.","journal-title":"J Proteome Res"},{"issue":"12","key":"9632_CR37","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1074\/mcp.M112.019919","volume":"11","author":"K Imami","year":"2012","unstructured":"Imami K, et al. Temporal profiling of lapatinib-suppressed phosphorylation signals in EGFR\/HER2 pathways. Mol Cell Proteom. 2012;11(12):1741\u201357.","journal-title":"Mol Cell Proteom"},{"issue":"12","key":"9632_CR38","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1074\/mcp.M112.019984","volume":"11","author":"H Johnson","year":"2012","unstructured":"Johnson H, et al. Molecular characterization of EGFR and EGFRvIII signaling networks in human glioblastoma tumor xenografts. Mol Cell Proteom. 2012;11(12):1724\u201340.","journal-title":"Mol Cell Proteom"},{"issue":"42","key":"9632_CR39","doi-asserted-by":"publisher","first-page":"15656","DOI":"10.1021\/acs.analchem.3c02856","volume":"95","author":"HI Stewart","year":"2023","unstructured":"Stewart HI, et al. Parallelized Acquisition of Orbitrap and Astral Analyzers Enables High-Throughput Quantitative Analysis. Anal Chem. 2023;95(42):15656\u201364.","journal-title":"Anal Chem"},{"issue":"12","key":"9632_CR40","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1038\/s41587-023-02099-7","volume":"42","author":"UH Guzman","year":"2024","unstructured":"Guzman UH, et al. Ultra-fast label-free quantification and comprehensive proteome coverage with narrow-window data-independent acquisition. Nat Biotechnol. 2024;42(12):1855\u201366.","journal-title":"Nat Biotechnol"},{"issue":"3","key":"9632_CR41","doi-asserted-by":"publisher","first-page":"e0264138","DOI":"10.1371\/journal.pone.0264138","volume":"17","author":"CA Milbury","year":"2022","unstructured":"Milbury CA, et al. Clinical and analytical validation of FoundationOne\u00aeCDx, a comprehensive genomic profiling assay for solid tumors. PLoS ONE. 2022;17(3):e0264138.","journal-title":"PLoS ONE"},{"issue":"1","key":"9632_CR42","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1038\/s41467-020-14381-2","volume":"11","author":"S Satpathy","year":"2020","unstructured":"Satpathy S, et al. Microscaled proteogenomic methods for precision oncology. Nat Commun. 2020;11(1):532.","journal-title":"Nat Commun"},{"issue":"1","key":"9632_CR43","doi-asserted-by":"publisher","first-page":"13814","DOI":"10.1038\/s41598-018-32072-3","volume":"8","author":"CJ Sande","year":"2018","unstructured":"Sande CJ, et al. Untargeted analysis of the airway proteomes of children with respiratory infections using mass spectrometry based proteomics. Sci Rep. 2018;8(1):13814.","journal-title":"Sci Rep"},{"issue":"3","key":"9632_CR44","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1021\/acs.jproteome.5b00046","volume":"14","author":"RB Braakman","year":"2015","unstructured":"Braakman RB, et al. Integrative analysis of genomics and proteomics data on clinical breast cancer tissue specimens extracted with acid guanidinium thiocyanate-phenol-chloroform. J Proteome Res. 2015;14(3):1627\u201336.","journal-title":"J Proteome Res"},{"issue":"11","key":"9632_CR45","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1038\/s43018-021-00259-9","volume":"2","author":"J Lehtio","year":"2021","unstructured":"Lehtio J, et al. Proteogenomics of non-small cell lung cancer reveals molecular subtypes associated with specific therapeutic targets and immune evasion mechanisms. Nat Cancer. 2021;2(11):1224\u201342.","journal-title":"Nat Cancer"},{"key":"9632_CR46","doi-asserted-by":"publisher","unstructured":"Mosquim Junior S, Siino V, Ryd\u00e9n L, Vallon-Christersson J, Levander F. Choice of High-Throughput Proteomics Method Affects Data Integration with Transcriptomics and the Potential Use in Biomarker Discovery. Cancers (Basel). 2022 Nov 23;14(23):5761. https:\/\/doi.org\/10.3390\/cancers14235761","DOI":"10.3390\/cancers14235761"},{"key":"9632_CR47","doi-asserted-by":"publisher","first-page":"100078","DOI":"10.1016\/j.mcpro.2021.100078","volume":"20","author":"F Rolfs","year":"2021","unstructured":"Rolfs F, et al. Feasibility of Phosphoproteomics on Leftover Samples After RNA Extraction With Guanidinium Thiocyanate. Mol Cell Proteom. 2021;20:100078.","journal-title":"Mol Cell Proteom"},{"key":"9632_CR48","doi-asserted-by":"publisher","unstructured":"Hasegawa Y, Otoki Y, McClorry S, Coates LC, Lombardi RL, Taha AY, Slupsky CM. Optimization of a Method for the Simultaneous Extraction of Polar and Non-Polar Oxylipin Metabolites, DNA, RNA, Small RNA, and Protein from a Single Small Tissue Sample. Methods Protoc. 2020 Aug 26;3(3):61. https:\/\/doi.org\/10.3390\/mps3030061","DOI":"10.3390\/mps3030061"},{"issue":"11","key":"9632_CR49","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1038\/nprot.2013.141","volume":"8","author":"S Pena-Llopis","year":"2013","unstructured":"Pena-Llopis S, Brugarolas J. Simultaneous isolation of high-quality DNA, RNA, miRNA and proteins from tissues for genomic applications. Nat Protoc. 2013;8(11):2240\u201355.","journal-title":"Nat Protoc"},{"issue":"1","key":"9632_CR50","doi-asserted-by":"publisher","first-page":"e114","DOI":"10.1002\/cpsc.114","volume":"54","author":"JX Zhang","year":"2020","unstructured":"Zhang JX, et al. High-throughput Preparation of DNA, RNA, and Protein from Cryopreserved Human iPSCs for Multi-omics Analysis. Curr Protoc Stem Cell Biol. 2020;54(1):e114.","journal-title":"Curr Protoc Stem Cell Biol"},{"issue":"5","key":"9632_CR51","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1074\/mcp.TIR118.001270","volume":"18","author":"TS Batth","year":"2019","unstructured":"Batth TS, et al. Protein Aggregation Capture on Microparticles Enables Multipurpose Proteomics Sample Preparation. Mol Cell Proteom. 2019;18(5):1027\u201335.","journal-title":"Mol Cell Proteom"},{"key":"9632_CR52","unstructured":"Russell JD, Murphy S. Agilent AssayMAP bravo technology enables reproducible automated phosphopeptide enrichment from complex mixtures using high\u2013capacity Fe(III)\u2013NTA cartridges. 1\u201315. Retrieved from https:\/\/www.agilent.com\/cs\/library\/applications\/5991-6073EN.pdf%0Ahttps:\/\/www.agilent.com\/en\/products\/automationsolutions\/protein-sample-preparation\/ assaymap-bravo-platform#literature. 2016."},{"issue":"4","key":"9632_CR53","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1021\/pr101065j","volume":"10","author":"J Cox","year":"2011","unstructured":"Cox J, et al. Andromeda: a peptide search engine integrated into the MaxQuant environment. J Proteome Res. 2011;10(4):1794\u2013805.","journal-title":"J Proteome Res"},{"issue":"9","key":"9632_CR54","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1074\/mcp.M113.031591","volume":"13","author":"J Cox","year":"2014","unstructured":"Cox J, et al. Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ. Mol Cell Proteom. 2014;13(9):2513\u201326.","journal-title":"Mol Cell Proteom"},{"issue":"8","key":"9632_CR55","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/nbt.3908","volume":"35","author":"G Rosenberger","year":"2017","unstructured":"Rosenberger G, et al. Inference and quantification of peptidoforms in large sample cohorts by SWATH-MS. Nat Biotechnol. 2017;35(8):781\u20138.","journal-title":"Nat Biotechnol"},{"issue":"1","key":"9632_CR56","doi-asserted-by":"publisher","first-page":"3944","DOI":"10.1038\/s41467-022-31492-0","volume":"13","author":"V Demichev","year":"2022","unstructured":"Demichev V, et al. dia-PASEF data analysis using FragPipe and DIA-NN for deep proteomics of low sample amounts. Nat Commun. 2022;13(1):3944.","journal-title":"Nat Commun"},{"issue":"5","key":"9632_CR57","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1074\/mcp.M114.044305","volume":"14","author":"R Bruderer","year":"2015","unstructured":"Bruderer R, et al. Extending the limits of quantitative proteome profiling with data-independent acquisition and application to acetaminophen-treated three-dimensional liver microtissues. Mol Cell Proteom. 2015;14(5):1400\u201310.","journal-title":"Mol Cell Proteom"},{"issue":"D1","key":"9632_CR58","doi-asserted-by":"publisher","first-page":"D523","DOI":"10.1093\/nar\/gkac1052","volume":"51","author":"C UniProt","year":"2023","unstructured":"UniProt C. UniProt: the Universal Protein Knowledgebase in 2023. Nucleic Acids Res. 2023;51(D1):D523\u201331.","journal-title":"Nucleic Acids Res"},{"key":"9632_CR59","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/1471-2105-7-44","volume":"7","author":"RS Kim","year":"2006","unstructured":"Kim RS, Ji H, Wong WH. An improved distance measure between the expression profiles linking co-expression and co-regulation in mouse. BMC Bioinformatics. 2006;7:44.","journal-title":"BMC Bioinformatics"},{"issue":"18","key":"9632_CR60","doi-asserted-by":"publisher","first-page":"2985","DOI":"10.1002\/rcm.3173","volume":"21","author":"LH Wang","year":"2007","unstructured":"Wang LH, et al. pFind 2.0: a software package for peptide and protein identification via tandem mass spectrometry. Rapid Commun Mass Spectrom. 2007;21(18):2985\u201391.","journal-title":"Rapid Commun Mass Spectrom"},{"issue":"11","key":"9632_CR61","doi-asserted-by":"publisher","first-page":"5286","DOI":"10.1021\/ac404246w","volume":"86","author":"C Liu","year":"2014","unstructured":"Liu C, et al. pQuant improves quantitation by keeping out interfering signals and evaluating the accuracy of calculated ratios. Anal Chem. 2014;86(11):5286\u201394.","journal-title":"Anal Chem"},{"issue":"5","key":"9632_CR62","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/s41587-021-01145-6","volume":"40","author":"A Santos","year":"2022","unstructured":"Santos A, et al. A knowledge graph to interpret clinical proteomics data. Nat Biotechnol. 2022;40(5):692\u2013702.","journal-title":"Nat Biotechnol"},{"issue":"11","key":"9632_CR63","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon P, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498\u2013504.","journal-title":"Genome Res"},{"issue":"1","key":"9632_CR64","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1074\/mcp.M112.020115","volume":"12","author":"AP Boyer","year":"2013","unstructured":"Boyer AP, et al. Quantitative proteomics with siRNA screening identifies novel mechanisms of trastuzumab resistance in HER2 amplified breast cancers. Mol Cell Proteom. 2013;12(1):180\u201393.","journal-title":"Mol Cell Proteom"},{"issue":"43","key":"9632_CR65","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545\u201350.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"D1","key":"9632_CR66","doi-asserted-by":"publisher","first-page":"D447","DOI":"10.1093\/nar\/gkv1145","volume":"44","author":"JA Vizcaino","year":"2016","unstructured":"Vizcaino JA, et al. 2016 update of the PRIDE database and its related tools. Nucleic Acids Res. 2016;44(D1):D447\u201356.","journal-title":"Nucleic Acids Res"},{"key":"9632_CR67","doi-asserted-by":"publisher","unstructured":"Eriksen M, Hansen AM, Nielsen AB, Mundt F, Mann M, Lassen U, Ahlborn LB, H\u00f8jgaard M, Spanggaard I, Qvortrup C, Yde CW, Rohrberg KS. Multiomics Identifies Potential Molecular Profiles Associated With Outcomes After BRAF-Targeted Therapy in Patients With BRAF V600E-Mutated Advanced Solid Tumors. JCO Precis Oncol. 2025 Mar;9:e2400266. https:\/\/doi.org\/10.1200\/PO.24.00266","DOI":"10.1200\/PO.24.00266"}],"container-title":["Clinical Proteomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12014-026-09632-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12014-026-09632-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12014-026-09632-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T17:02:01Z","timestamp":1790442121000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12014-026-09632-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,20]]},"references-count":67,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["9632"],"URL":"https:\/\/doi.org\/10.1186\/s12014-026-09632-1","relation":{},"ISSN":["1542-6416","1559-0275"],"issn-type":[{"value":"1542-6416","type":"print"},{"value":"1559-0275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,20]]},"assertion":[{"value":"11 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Patients included in this study were enrolled in the Copenhagen Prospective Personalized Oncology (CoPPO) study [\n                      \n                      ]. The CoPPO study was approved by the regional ethics committee (reference number 1300530), and all participants provided written informed consent prior to inclusion.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Earlier versions of this study were previously available on the bioRxiv preprint server: https:\/\/www.biorxiv.org\/content\/\n                      \n                      .","order":3,"name":"Ethics","label":"Prior Presentation","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"MM is an indirect investor in Evosep Biosciences.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"45"}}